Shah Pritesh's Form 4 filing
NovoCure Ltd (NVCR) · filed Mar 11, 2022
- Accession no.
- 0001645113-22-000031
- Filed
- Mar 11, 2022
- Trade date
- Jul 31, 2021-Mar 9, 2022
- Filing delay
- 223 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $261.2K. It was filed 223 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Shah PriteshCIK 0001744884 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 31, 2021 | Ordinary Shares | MOption exerciseAcquired | +3,717 | $154.01 | +$572,455.17 | 85,625 | Direct | |
| Mar 9, 2022 | Ordinary Shares | SSaleDisposed | −3,669 | $71.19 | −$261,196.11 | 83,187 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 31, 2021 | Ordinary Shares | MOption exerciseDisposed | −3,717 | $0.00 | $0 | 3,717 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.